Pain Management Clinic in London for spinal chronic pain with minimally invasive day surgeries or injections

What if spinal pain relief didn’t require a long hospital stay, heavy opioids, or a last-resort operation? At Liv Harley Street Hospital, we see this every week: people with stubborn low back pain regaining control through minimally invasive day procedures and targeted injections. A new multicentre trial has just added weight to this approach—showing that a 60-day percutaneous peripheral nerve stimulation (PNS) programme can deliver meaningful, sustained relief for chronic low back pain compared with usual interventional care. For anyone searching for a pain management clinic in London for spinal chronic pain with minimally invasive day surgeries or injections, the evidence is getting clearer—and more hopeful.

Key takeaways at a glance

• In a pragmatic randomised controlled trial of 230 adults with chronic low back pain, 55% receiving 60-day percutaneous PNS achieved at least 50% pain relief at 3 months vs 26% with usual interventional care (p < 0.001).
• Benefits extended beyond pain: disability, pain interference, quality of life, and analgesic use all improved more with PNS, with gains maintained to 6 months.
• These are outpatient, minimally invasive strategies that can complement physiotherapy, behavioural rehab, and medication tapering plans.
• Reference: Pain Medicine, 2025; DOI: 10.1093/pm/pnaf147; PubMed: 41138174.

What the new trial tells us about PNS for chronic low back pain

The pragmatic RCT compared two pathways: a 60-day percutaneous PNS protocol versus physician-directed usual interventional management (which may include physical therapy, injections, radiofrequency ablation, neurostimulation, or surgery). At the 3‑month primary endpoint, 55% of PNS patients reported at least 50% pain reduction (95% CI 45–65%), compared with 26% in the usual-care group (95% CI 17–34%; p < 0.001). Improvements in disability, pain interference, health-related quality of life, and reductions in analgesic consumption aligned with the pain results and were sustained to 6 months. Full abstract: 41138174; DOI: 10.1093/pm/pnaf147.

How percutaneous PNS fits into a London pain management pathway

PNS uses small percutaneous leads placed near target peripheral nerves to modulate pain signalling. The therapy phase typically lasts 60 days, after which leads are removed. The intent is to “reset” neural pathways and facilitate rehabilitation, not to create permanent implants. For suitable patients—especially those who have hit a ceiling with physiotherapy and standard injections—PNS can bridge the gap before considering more invasive surgery.

• Day-case procedure under local anaesthesia or light sedation.
• Programmable, adjustable stimulation tailored to pain distribution.
• Compatible with a multi-disciplinary programme (physiotherapy, cognitive-behavioural strategies, sleep optimisation).

Minimally invasive day surgeries and injections we use alongside PNS

• Targeted spinal injections: facet joint, medial branch, and transforaminal epidural injections for diagnosis and relief.
• Radiofrequency denervation: thermally modulates medial branch nerves when facetogenic pain is confirmed.
• Sacroiliac joint therapies: image-guided injections and, in selected cases, radiofrequency lesioning.
• Biologic adjuncts: in carefully chosen cases, regenerative injections are considered within evidence-based protocols.

Each option is selected via diagnostic blocks, clinical examination, and imaging where appropriate. The goal is pragmatic: reduce pain, restore function, and accelerate return to normal activity without prolonged downtime.

Who might benefit from PNS and related day-case interventions?

Patients with chronic low back pain who:

• Have persistent symptoms despite structured physiotherapy and analgesic optimisation.
• Exhibit neuropathic or mixed pain features, or focal pain amenable to peripheral nerve targeting.
• Prefer reversible, non-destructive treatments before considering surgery.
• Need a recovery-friendly approach due to work or caregiving commitments.

Answers at a glance: common questions

Is PNS an alternative to spinal cord stimulation?

Often, yes—especially when pain is focal and peripheral targets are clear. PNS is temporary and removable after 60 days, whereas SCS is typically a permanent implant following a trial period.

How quickly might I notice improvement?

Many patients report benefit within days to weeks. In the trial, clinically meaningful relief was assessed at 3 months, with gains persisting to 6 months.

Is it compatible with physiotherapy?

Absolutely. We integrate PNS with graded activity, core stabilisation, and pacing, which can enhance functional outcomes.

What about safety?

As a percutaneous, day-case technique, PNS avoids open surgery. As with any procedure, risks include local discomfort, skin irritation, or lead displacement; these are minimised with careful technique and follow-up.

Why evidence-backed, minimally invasive care matters

Chronic low back pain is a leading cause of disability worldwide. In the UK, back pain drives millions of GP consultations and work absences annually; the ONS reports musculoskeletal problems as a major contributor to long-term sickness in the workforce (ONS). Evidence-driven, minimally invasive options can reduce reliance on opioids—NHS prescribing data show ongoing efforts to curb long-term opioid use for chronic pain (NICE NG193)—while giving patients a practical path back to function.

Our expert view from Harley Street

We favour treatments that are reversible, measurable, and paired with rehabilitation. The latest RCT strengthens the case for 60‑day percutaneous PNS when standard interventional care has plateaued. It’s not a silver bullet, but in a carefully selected cohort, it can move the needle on pain, disability, and quality of life—without burning bridges for future options.

What to expect at a Pain Management Clinic in London for spinal chronic pain

1. Assessment: detailed history, examination, red-flag screening, and review of imaging.
2. Diagnostic precision: targeted blocks to identify pain generators.
3. Plan: stepwise pathway prioritising minimally invasive day surgeries or injections.
4. Treatment: image-guided procedures (e.g., PNS, radiofrequency, targeted injections) with same-day discharge.
5. Rehabilitation: physiotherapy, pacing, sleep and mood strategies, and medication optimisation.
6. Review: outcome tracking and adjustment, with escalation only if needed.

Conclusion: a smarter path to spinal pain relief in London

If you’re weighing options at a pain management clinic in London for spinal chronic pain with minimally invasive day surgeries or injections, percutaneous 60‑day PNS now has robust RCT support—55% achieving at least 50% pain relief vs 26% with usual care at 3 months, with functional gains to 6 months (10.1093/pm/pnaf147; PubMed 41138174). In our experience, combining such interventions with rehabilitation offers the best chance of durable improvement—getting you back to the things that matter, sooner and with less disruption.

Best Pain Management Clinic in London with minimally invasive day-surgery